The humoral immune response against SE and PPV developed by ERYSENG® PARVO/LEPTO was faster, higher and lasted longer than the response obtained with vaccine A. This situation guarantees better protection for sows during the gestation period and would prevent the presence of negative sub-populations susceptible to suffering from clinical diseases with the consequent associated reproduction losses.
På dette website bruger vi egne cookies og cookies sat af tredjeparts tjeneste med henblik på at forbedre vores services og navigationsmuligheder. Hvis du vælger at browse videre, anser vi det for din accept af vores brug af disse cookies. For yderligere oplysninger,
se vores cookiepolitik.Jeg accepterer